Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Make way for MiniMed! Medtronic's diabetes division has filed the necessary paperwork to go public. The company hopes to be traded on Nasdaq under the symbol MMED.
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
AI and patient care are “top of mind” for healthcare executives in 2024. The pairing seems opportune, since the surveyed leaders see the burgeoning technology as a key tool for improving the perennial mission.
The company has entered into a definitive agreement to purchase Core Ventures, resulting in the Florida Cancer Specialists & Research Institute aligning with its oncology network.
Kaiser Permanente AI exec Daniel Yang, MD: ‘With a focus on building trust, we use AI only when it advances our core mission of delivering high-quality, affordable healthcare services.’
On Tuesday, a federal court in Texas ruled the Federal Trade Commission overstepped its statutory authority in issuing the ban. It’s been officially halted, pending appeal.
Gina Congi was told her daughter was discharged from Mercy San Juan Medical Center. A year later, Jessie Peterson’s body was found in cold storage, a pending lawsuit claims.
Smart machines have watched over the little bundle of joy practically since conception—and will be an omnipresent part of his or her life for decades to come. What can we tell this individual their life will be like?